These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 15690770

  • 1. [Changes in national insurance reimbursement with introduction of the DPC package payment system for 131I therapy for hyperthyroidism].
    Watanabe S, Kosuda S, Yano F, Abe K, Kusano S, Tanaka Y.
    Kaku Igaku; 2004 Nov; 41(4):415-9. PubMed ID: 15690770
    [Abstract] [Full Text] [Related]

  • 2. [Chronological change in the national health insurance reimbursement based on the DPC package payment system regarding 131I internal therapy].
    Kunishima M, Sakaguchi C, Kita T, Watanabe S, Yano F, Soga S, Shinmoto H, Kosuda S.
    Kaku Igaku; 2008 May; 45(2):115-8. PubMed ID: 19591406
    [Abstract] [Full Text] [Related]

  • 3. Impact of the Japanese diagnosis procedure combination-based payment system in Japan.
    Wang K, Li P, Chen L, Kato K, Kobayashi M, Yamauchi K.
    J Med Syst; 2010 Feb; 34(1):95-100. PubMed ID: 20192060
    [Abstract] [Full Text] [Related]

  • 4. Case-mix payment in Japanese medical care.
    Okamura S, Kobayashi R, Sakamaki T.
    Health Policy; 2005 Nov; 74(3):282-6. PubMed ID: 16226139
    [Abstract] [Full Text] [Related]

  • 5. [DRG: the new hospital reimbursement system for Germany. Part 1: Introduction].
    Rochell B, Roeder N.
    Urologe A; 2003 Apr; 42(4):471-84. PubMed ID: 12715120
    [No Abstract] [Full Text] [Related]

  • 6. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L, De Palma D, Ceriani L, Vanoli P, Garancini S, Tordiglione M, Tarolo GL.
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [Abstract] [Full Text] [Related]

  • 7. [DRG: the new hospital reimbursement system for Germany. Part 2: The option system 2003].
    Rochell B, Roeder N.
    Urologe A; 2003 Apr; 42(4):485-95. PubMed ID: 12715121
    [No Abstract] [Full Text] [Related]

  • 8. Diagnosis and radioablation treatment of toxic multinodular goiter in a hemodialysis patient.
    Demko TM, Tulchinsky M, Miller KL, Cheung JY, Groff JA.
    Am J Kidney Dis; 1998 Apr; 31(4):698-700. PubMed ID: 9531189
    [Abstract] [Full Text] [Related]

  • 9. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA, Daykin J, Holder R, Sheppard MC.
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [Abstract] [Full Text] [Related]

  • 10. [The new G-DRG case reimbursement system. First adjustment of ENT case groups to the German cost structure].
    Steuer-Vogt MK, Alberty J, Büter J, Leuwer R, Schubotz C, Dietz A, Metzger F, Hörmann K.
    HNO; 2003 May; 51(5):369-74. PubMed ID: 12835852
    [No Abstract] [Full Text] [Related]

  • 11. [Consequences of new patient discharge guidelines on the cost structure of radioiodine therapy].
    Dietlein M, Troche CJ, Moka D, Bausch V, Lauterbach KW, Schicha H.
    Nuklearmedizin; 1998 Jan; 37(1):33-40. PubMed ID: 9467168
    [Abstract] [Full Text] [Related]

  • 12. Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goiters.
    Huysmans AK, Hermus RM, Edelbroek MA, Tjabbes T, Oostdijk, Ross HA, Corstens FH, Kloppenborg PW.
    Thyroid; 1997 Aug; 7(4):535-9. PubMed ID: 9292939
    [Abstract] [Full Text] [Related]

  • 13. [Radioiodine 131I therapy of hyperthyroidism on an outpatient basis - safe, effective and economic option].
    Jiskra J, Kubinyi J, Telička Z.
    Vnitr Lek; 2012 Feb; 58(2):94-8. PubMed ID: 22463087
    [Abstract] [Full Text] [Related]

  • 14. [Development of the reimbursement system based on DPC].
    Nakamura K.
    Rinsho Byori; 2004 Nov; 52(11):906-14. PubMed ID: 15658470
    [Abstract] [Full Text] [Related]

  • 15. [Approval of additional management fee in medical insurance and its change].
    Mori M.
    Rinsho Byori; 2009 Dec; 57(12):1182-5. PubMed ID: 20077819
    [Abstract] [Full Text] [Related]

  • 16. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.
    Allahabadia A, Daykin J, Sheppard MC, Gough SC, Franklyn JA.
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3611-7. PubMed ID: 11502786
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC, Zanin DE, Zweers EJ.
    Ned Tijdschr Geneeskd; 2002 Sep 28; 146(39):1837-41. PubMed ID: 12382370
    [Abstract] [Full Text] [Related]

  • 18. [Status of 3 years of hyperthyroidism treatment with iodine 131].
    Delgrange E, Weber E, Michel L, De Coster P, Buysschaert M, Donckier J.
    Acta Clin Belg; 1994 Sep 28; 49(5):200-7. PubMed ID: 7992563
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. 131I therapy of toxic and non-toxic goiters.
    Beckers C.
    Q J Nucl Med; 1999 Dec 28; 43(4):291-6. PubMed ID: 10731779
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.